Details for New Drug Application (NDA): 019462
✉ Email this page to a colleague
The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Summary for 019462
| Tradename: | PEPCID |
| Applicant: | Bausch |
| Ingredient: | famotidine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019462
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 15, 1986 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 15, 1986 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 019462
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | PEPCID | famotidine | TABLET;ORAL | 019462-001 | Oct 15, 1986 | 4,283,408*PED | ⤷ Get Started Free |
| Bausch | PEPCID | famotidine | TABLET;ORAL | 019462-002 | Oct 15, 1986 | 4,283,408*PED | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
